Prostate Adenocarcinoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
Z
Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer - 2021
Completed
  • Prostate Cancer Recurrent
  • +2 more
  • Epidiolex Oral Liquid Product
  • Lexington, Kentucky
    Markey Cancer Center
2021-10-07
Oct 7, 2021
U
Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance
Active, not recruiting
Has Results
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-09-17
Sep 17, 2021
J
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
Recruiting
  • Prostate Adenocarcinoma
  • +7 more
  • High-Dose Rate Brachytherapy
  • Stereotactic Body Radiation Therapy
  • Los Angeles, California
    University of California at Los Angeles / Jonsson Comprehensive
2021-10-07
Oct 7, 2021
A
Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer
Recruiting
  • Prostate Adenocarcinoma
  • Bethesda, Maryland
    National Cancer Institute
2021-10-01
Oct 1, 2021
M
Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy
Active, not recruiting
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • Quality-of-Life Assessment
  • Scottsdale, Arizona
  • +2 more
2021-10-06
Oct 6, 2021
F
Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study
Suspended
  • Localized Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Best Practice
  • +4 more
  • Seattle, Washington
  • +1 more
2021-10-04
Oct 4, 2021
U
Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy
Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • TRUS biopsy
  • Tucson, Arizona
    University of Arizona
2021-09-21
Sep 21, 2021
J
68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer - 2021
Completed
  • Biochemically Recurrent Prostate Carcinoma
  • +8 more
  • Computed Tomography
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
2021-09-29
Sep 29, 2021
U
Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer
Active, not recruiting
  • Hormone-Resistant Prostate Cancer
  • +6 more
  • Pembrolizumab
  • pTVG-HP Plasmid DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
2021-09-28
Sep 28, 2021
N
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
Suspended
  • Metastatic Malignant Neoplasm in the Bone
  • +6 more
  • Abiraterone Acetate
  • +13 more
  • Duarte, California
  • +102 more
2021-09-22
Sep 22, 2021
N
Testing the Addition of the Drugs, Apalutamide and Abiraterone Acetate With Prednisone, to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer
Suspended
  • Positive Lymph Node
  • +12 more
  • Abiraterone Acetate
  • +6 more
  • Long Beach, California
  • +185 more
2021-09-22
Sep 22, 2021
U
Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer
Recruiting
  • Recurrent Prostate Carcinoma
  • +5 more
  • Hypofractionated Radiation Therapy
  • +5 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
2021-09-27
Sep 27, 2021
S
Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate Cancer
Enrolling by invitation
  • Prostate Cancer
  • +5 more
  • 131I-PSMA-1095 Radioligand Therapy (RLT)
  • Montreal, Quebec, Canada
    Stephan Probst
2021-09-20
Sep 20, 2021
M
Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer
Recruiting
  • Prostate Adenocarcinoma
  • Prostate Carcinoma
  • Magnetic Resonance Imaging
  • Houston, Texas
    M D Anderson Cancer Center
2021-09-14
Sep 14, 2021
M
Radiation Therapy (Hypofractionated Proton Beam Therapy or IMRT) for the Treatment of Recurrent, Oligometastatic Prostate Cancer Following Primary Localized Treatment
Recruiting
  • Metastatic Prostate Adenocarcinoma
  • +6 more
  • Intensity-Modulated Radiation Therapy
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2021-09-20
Sep 20, 2021
A
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer
Active, not recruiting
  • Prostate Adenocarcinoma
  • Gallium Ga 68-labeled GRPR Antagonist BAY86-7548
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
2021-09-22
Sep 22, 2021
N
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score
Not yet recruiting
  • Prostate Adenocarcinoma
  • (no location specified)
2021-09-17
Sep 17, 2021
R
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors
Recruiting
  • Cancer Survivor
  • +19 more
  • Dietary Intervention
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2021-09-17
Sep 17, 2021
N
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer
Not yet recruiting
  • Oligometastatic Prostate Carcinoma
  • +2 more
  • Placebo Administration
  • +3 more
  • (no location specified)
2021-09-13
Sep 13, 2021
U
Trial of Quercetin, Bromelain, Rye Flower Pollen & Papain on Reducing Severity of Radiation-Induced Prostatitis
Not yet recruiting
  • Prostate Adenocarcinoma
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
2021-09-20
Sep 20, 2021
U
Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer - 2021
Withdrawn
  • Prostate Adenocarcinoma
  • MVA-BN-Brachyury
  • Salt Lake City, Utah
    Huntsman Cancer Institute
2021-09-21
Sep 21, 2021
U
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
Recruiting
  • Prostate Adenocarcinoma
  • Prostate Cancer
  • Hyperpolarized Carbon C 13 Pyruvate
  • +2 more
  • San Francisco, California
    University of California, San Francisco
2021-09-14
Sep 14, 2021
U
Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer
Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +7 more
  • Antiandrogen Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-09-17
Sep 17, 2021
E
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC
Recruiting
  • Metastatic Prostate Cancer
  • Prostate Adenocarcinoma
  • Tucson, Arizona
  • +185 more
2021-09-15
Sep 15, 2021
N
Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer
Active, not recruiting
  • Prostate Adenocarcinoma
  • +6 more
  • Gonadotrophin Releasing Hormone
  • +2 more
  • Tucson, Arizona
  • +79 more
2021-09-14
Sep 14, 2021